Hudson Bay Capital Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.06M | Buy |
290,000
+40,000
| +16% | +$560K | 0.01% | 430 |
|
|
2025
Q1 | $3.4M | Buy |
250,000
+157,500
| +170% | +$2.14M | 0.01% | 422 |
|
|
2024
Q4 | $1.89M | Buy |
92,500
+58,000
| +168% | +$1.18M | 0.01% | 503 |
|
|
2024
Q3 | $1M | Sell |
34,500
-140,500
| -80% | -$4.09M | ﹤0.01% | 489 |
|
|
2024
Q2 | $4.06M | Sell |
175,000
-45,000
| -20% | -$1.04M | 0.02% | 331 |
|
|
2024
Q1 | $4.51M | Buy |
220,000
+45,000
| +26% | +$923K | 0.03% | 273 |
|
|
2023
Q4 | $3.76M | Buy |
+175,000
| New | +$3.76M | 0.02% | 296 |
|